top of page

South Africa

The SeroSelectTB test will be evaluated at the Wallacedene, Scottsdene and Bloekombos health clinics in the Northern Health District of Cape Town, South Africa. TB suspects self-reporting to the study sites will be randomised in two arms: standard-of-care or SeroSelectTB. In South Africa, 2314 TB suspects will be enrolled in each study arm.


This section will be updated as the clinical trial proceeds.

Walk Through Site Video - August 2021

bottom of page